Optometry News

KIAWAH ISLAND, S.C. — Drug-eluting implants in various stages of study and approval may provide efficient, sustained drug delivery, overcoming barriers to penetration, according to a speaker at Kiawah Eye.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Steve Pakola, MD, chief medical officer of Regenxbio, shares updates on the company’s retina programs.

In previous posts, I discussed the great potential for the use of AI-enabled technology for ophthalmology practice marketing, particularly in the area of marketing content production.

NASHVILLE, Tenn. — A lipid-containing eye drop not only was shown to be noninferior to non-lipid-containing drops but it also improved patients’ dry eye signs and symptoms, according to a study presented at Optometry’s Meeting.

KIAWAH ISLAND, S.C. — In a study presented at Kiawah Eye, instrument-based screening for amblyopia risk factors and refractive error showed different sensitivity levels depending on ethnicity or eye coloration.

NASHVILLE, Tenn. — Although most ocular injuries from Nerf-type gun projectiles are limited to the anterior segment and have good long-term visual outcomes, researchers strongly advise safety eye wear during use.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Dilsher S. Dhoot, MD, of California Retina Consultants, discusses positive 40-week data from the phase 1 HELIOS trial.

KIAWAH ISLAND, S.C. — Ophthalmologists should consider implementing cosmetic options into their practices to meet growing demands and attract more patients, according to a presenter at Kiawah Eye.

June is Pride Month, and this year marks the 55th anniversary of the 1969 Stonewall uprising in New York — a pivotal event in our nation’s LGBTQIA+ history.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Kester Nahen, PhD, CEO of Notal Vision, discusses the patient self-operated AI-powered Scanly Home OCT device.